Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04861467 · UNKNOWN
Trial details
- NCT number
- NCT04861467
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2025-07-31
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.